Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)

Genomics BioSci & Tech. Statistics

Total Valuation

TPEX:4195 has a market cap or net worth of TWD 1.78 billion. The enterprise value is 2.31 billion.

Market Cap	1.78B
Enterprise Value	2.31B

Important Dates

The next estimated earnings date is Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4195 has 72.45 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	72.45M
Shares Outstanding	72.45M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.16%
Owned by Institutions (%)	4.58%
Float	56.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.93
PB Ratio	2.91
P/TBV Ratio	3.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-27.57
EV / Sales	3.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.16

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.93.

Current Ratio	1.28
Quick Ratio	0.65
Debt / Equity	0.93
Debt / EBITDA	n/a
Debt / FCF	-2.52
Interest Coverage	-8.27

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-7.98%
Return on Capital Employed (ROCE)	-11.16%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.47% in the last 52 weeks. The beta is 0.15, so TPEX:4195's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	+31.47%
50-Day Moving Average	24.92
200-Day Moving Average	22.17
Relative Strength Index (RSI)	42.76
Average Volume (20 Days)	259,468

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4195 had revenue of TWD 607.89 million and -83.60 million in losses. Loss per share was -1.15.

Revenue	607.89M
Gross Profit	180.75M
Operating Income	-103.33M
Pretax Income	-109.84M
Net Income	-83.60M
EBITDA	-44.43M
EBIT	-103.33M
Loss Per Share	-1.15

Balance Sheet

The company has 126.66 million in cash and 571.12 million in debt, with a net cash position of -444.46 million or -6.13 per share.

Cash & Cash Equivalents	126.66M
Total Debt	571.12M
Net Cash	-444.46M
Net Cash Per Share	-6.13
Equity (Book Value)	613.12M
Book Value Per Share	7.38
Working Capital	123.47M

Cash Flow

In the last 12 months, operating cash flow was -108.07 million and capital expenditures -118.83 million, giving a free cash flow of -226.91 million.

Operating Cash Flow	-108.07M
Capital Expenditures	-118.83M
Free Cash Flow	-226.91M
FCF Per Share	-3.13

Margins

Gross margin is 29.73%, with operating and profit margins of -17.00% and -13.75%.

Gross Margin	29.73%
Operating Margin	-17.00%
Pretax Margin	-18.07%
Profit Margin	-13.75%
EBITDA Margin	-7.31%
EBIT Margin	-17.00%
FCF Margin	n/a

Dividends & Yields

TPEX:4195 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	-0.01%
Earnings Yield	-4.69%
FCF Yield	-12.73%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 8, 2023. It was a forward split with a ratio of 1.02.

Last Split Date	Aug 8, 2023
Split Type	Forward
Split Ratio	1.02

Scores

TPEX:4195 has an Altman Z-Score of 1.23 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.23
Piotroski F-Score	1